Relationship of neurocognition and treatment retention in subjects on opioid agonist treatment.

Opioid dependence affects several neurocognitive domains, which can negatively affect the treatment outcome. Examining the relationship between neurocognitive functions and short-term treatment retention in subjects on buprenorphine-naloxone-based agonist treatment. We recruited 56 subjects (aged be...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Substance Use Vol. 28; no. 5; pp. 685 - 692
Autores principales: Ghosh, Abhishek, Rana, Devender Kumar, Basu, Debasish, Mattoo, Surendra K., Roub, Fazle, Bammidi, Ravi
Formato: research tables/charts Journal Article
Publicado: Taylor & Francis Ltd 2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=172309345&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 172309345
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14659891
        ILV
      jtl: Journal of Substance Use
      issn: 14659891
      maglogo: Y
    pubinfo:
      dt: 2023
      vid: 28
      iid: 5
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        172309345
        157203881
        172309345
        172309345
        10.1080/14659891.2022.2084781
        172309345
      ppf: 685
      ppct: 7
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Relationship of neurocognition and treatment retention in subjects on opioid agonist treatment.
      aug:
        au:
          Ghosh, Abhishek
          Rana, Devender Kumar
          Basu, Debasish
          Mattoo, Surendra K.
          Roub, Fazle
          Bammidi, Ravi
        affil: Drug De-addiction and Treatment Centre, Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India
      sug:
        subj:
          Substance Dependence Drug Therapy
          Medication Compliance
          Cognition
          Functional Status
          Buprenorphine Therapeutic Use
          Naloxone Therapeutic Use
          Treatment Outcomes Evaluation
          Human
          Male
          Adult
          Correlational Studies
          Neuropsychological Tests
          Treatment Termination
          Descriptive Statistics
          Persons with Substance Use Disorders
          Tertiary Health Care
          India
          Mann-Whitney U Test
          Chi Square Test
          Fisher's Exact Test
          Logistic Regression
          Data Analysis Software
          Comparative Studies
          Adult: 19-44 years
          Male
      ab: Opioid dependence affects several neurocognitive domains, which can negatively affect the treatment outcome. Examining the relationship between neurocognitive functions and short-term treatment retention in subjects on buprenorphine-naloxone-based agonist treatment. We recruited 56 subjects (aged between 18 and 45 years) registered between March 2017 and December 2017. We excluded subjects dependent on other substances (except cannabis and tobacco), along with medical and other psychiatric comorbidities. During the first week of the agonist treatment, we assessed executive function, decision-making, attention, psychomotor speed, and working memory with the Wisconsin card sorting test (WCST), Iowa gambling test (IGT), and Trail making and verbal and visual N-back tests. Treatment retention was assessed after 12 weeks. The mean age of the subjects was 26 (±5.9) years. Twenty-eight (50%) subjects were retained in the treatment. Neurocognitive functions at the treatment entry did not differ between subjects retained in the treatment and those who dropped out. A higher severity and lower duration of dependence and use were associated with higher treatment discontinuation. The regression model, with the cognitive functions and significant clinical variables, could explain 38% variance for treatment retention. Neurocognitive functions at the treatment entry did not predict retention in opioid agonist treatment. There is some evidence of baseline cognitive functions predicting treatment retention in substance use disorders We wanted to test it in a group of patients on buprenorphine (naloxone)-based agonist management Relevant clinical and demographic variables were controlled for Executive functions, decision-making, attention, psychomotor speed, and working memory at the treatment entry did not predict retention at the end of three months Longer duration of opioid use (and dependence) was associated with better treatment retention
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N